ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging.

Area of Science:

• Neuroimaging
• Immunology
• Biotechnology

Background:

• Leukocyte adhesion molecules are upregulated on cerebral microvasculature during experimental autoimmune encephalitis (EAE).
• Visualizing these molecules in vivo is crucial for understanding and diagnosing neurological diseases.

Purpose of the Study:

• To develop and evaluate a novel, target-specific Magnetic Resonance Imaging (MRI) contrast agent for visualizing leukocyte adhesion molecules in the brain.
• To assess the efficacy of antibody-conjugated paramagnetic liposomes (ACPLs) in targeting intercellular adhesion molecule-1 (ICAM-1) during EAE.

Main Methods:

• Antibody-conjugated paramagnetic liposomes (ACPLs) targeting ICAM-1 were designed and administered to mice with EAE.
• Fluorescence microscopy was used to confirm ACPL localization to the central nervous system (CNS) microvasculature.
• High-resolution MRI was performed ex vivo on mouse brains to evaluate signal enhancement.

Main Results:

• Fluorescently-tagged ACPLs showed localization consistent with ICAM-1 upregulation in the CNS microvasculature.
• MRI of ACPL-treated brains demonstrated significant signal intensity enhancement compared to controls.
• The results indicate successful in vivo targeting and MRI detection of ICAM-1.

Conclusions:

• ACPLs serve as effective MRI contrast agents for visualizing specific molecules on vascular endothelium.
• This technology holds potential for non-invasive imaging of inflammatory conditions like EAE.
• Targeted ACPLs offer a promising approach for molecular imaging in neurological disease research.